All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Five-year outcome after STEMI in primary PCI era

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F21%3A43922027" target="_blank" >RIV/00216208:11120/21:43922027 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/21:N0000096

  • Result on the web

    <a href="https://doi.org/10.36290/kar.2020.048" target="_blank" >https://doi.org/10.36290/kar.2020.048</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.36290/kar.2020.048" target="_blank" >10.36290/kar.2020.048</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Five-year outcome after STEMI in primary PCI era

  • Original language description

    This review summarizes the information available from long-term follow-up after ST-elevation myocardial infarction (STEMI) in the primary percutaneous coronary intervention (p-PCI) era. The main aim of this review is to present an overview of long-term overall mortality, cardiac mortality, and major adverse cardiac events (MACE). We searched and analyzed trials with 5-year and longer follow-up periods published from January 2001 to December 2019. Only p-PCI trials were included. Overall mortality at 5-year follow-up was 9.3-23.3 % and annual overall mortality was around 2 % for the years following the first one after STEMI. Cardiac mortality at 5-year follow-up was 4.7-16.0 % and annual cardiac mortality was approximately 1.1-1.5 % for the years following the first one after STEMI. The cumulative incidences of reinfarction at 5-year follow-up, heart failure requiring admission, additional revascularization, and stroke were 5.0-18.0, 4.0-18.5 %, 19.0-37.1 %, and 2.6-8.0 %, respectively. The cumulative incidence of in-stent thrombosis was 2.6 %. The cumulative incidence of restenosis was 7.8 %. The results of the above-mentioned trials suggest a high proportion of cardiovascular deaths and MACE in the long-term follow-up period. With respect to these facts, questions arise as to how to reduce MACE and the possibility of routine use of coronary artery imaging in the follow-up.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Intervenční a akutní kardiologie

  • ISSN

    1213-807X

  • e-ISSN

  • Volume of the periodical

    20

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    5

  • Pages from-to

    106-110

  • UT code for WoS article

  • EID of the result in the Scopus database

    2-s2.0-85113774119